Rise in obese population and increase in sport-related injuries have boosted the growth of the global soft tissue repair market. The market across North America held the largest share in 2017, contributing around half of the market and is expected to continue its dominance throughout the study period.
The global soft tissue repair market was pegged at $16.55 billion in 2017 and is projected to reach $25.63 billion by 2025, registering a CAGR of 5.6% from 2017 to 2025.
Rise in obese population and increase in sport-related injuries have boosted the growth of the global soft tissue repair market. However, high cost of these procedures and lack of reimbursement provisions hamper the market growth. On the contrary, new product launches in developing countries are expected to create lucrative opportunities in the near future.
Download Sample Copy of this Report at https://www.alliedmarketresearch.com/request-sample/684
The global soft tissue repair market is divided on the basis of type, application, and geography. Based on type, the market is divided into tissue mesh, laparoscopic instrument, and fixation device. The tissue mesh segment is projected to manifest the fastest CAGR of 5.8% during the forecast period. However, the laparoscopic instrument segment dominated the market in 2017, contributing more than two-fifths of the market.
On the basis of application, the market is divided into breast reconstruction, dental repair, dural repair, head & neck product, hernia repair, orthopedic repair, pelvic & vaginal prolapse repair, and skin repair. The hernia repair segment held the largest share in 2017, accounting for one-fourth of the market. However, the dental repair segment is estimated to portray the fastest CAGR of 6.4% during the forecast period.
Check available discounts on this report at https://www.alliedmarketresearch.com/purchase-enquiry/684
The global soft tissue repair market is analyzed across various regions such as North America, Europe, Asia-Pacific, and LAMEA. The market across North America held the largest share in 2017, contributing around half of the market and is expected to continue its dominance throughout the study period. However, the market across the Asia-Pacific region is estimated to register the fastest CAGR during the forecast period.
The report provides an in-depth analysis of the major market players such as CryoLife, Inc., Allergan Plc. (LifeCell Corporation), Medtronic Plc., Athersys, Inc., Stryker Corporation, Integra Lifesciences Corporation, Smith & Nephew plc., Organogenesis Inc., Zimmer Biomet Holdings, Inc., and Becton, Dickinson and Company (C.R. Bard).
|Market size available for years||2017 – 2025|
|Base year considered||2018|
|Forecast period||2018 – 2025|
|Forecast units||Value (USD)|
|Segments covered||By Type, By Application|
|Geographies covered||North America, Europe, Asia-Pacific, LAMEA|
Tissue Diagnostics Market by Product (Consumables and Instruments), by Disease (Breast Cancer, Gastric Cancer, Lymphoma, Prostate Cancer, Non-Small Cell Lung Cancer, and Other Diseases), by Technology (Immunohistochemistry (IHC), In-Situ Hybridization (ISH), Digital Pathology & Workflow Management, and Special Staining), and by End User (Hospitals, Research Laboratories, Pharmaceutical Companies, Contract Research Organizations, and Others) – Global Opportunity Analysis and Industry Forecast, 2019-2026
Tissue Engineering Market by Type (Synthetic Materials, Biologically Derived Materials, and Others), and Application (Orthopedics, Musculoskeletal & Spine, Neurology, Cardiology & Vascular, Skin & Integumentary, and Others) – Global Opportunity Analysis and Industry Forecast, 2019-2026
5933 NE Win Sivers Drive
#205, Portland, OR 97220
Toll Free: +1-800-792-5285
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060